According to a report by Osul on September 8th, a recent survey released by the Progress Hub platform shows that 12.6% of adults in Brazil smoke, which is 7% lower than the global average, based on the implementation of the World Health Organization's Framework Convention on Tobacco Control.
A report released by the Brazilian Society of Dermatology (SBD) states that smoking can negatively impact the health of the skin, hair, and nails. The toxins in tobacco can damage collagen and elastin proteins and cause oxidative stress, leading to accelerated aging.
In addition, e-cigarettes also bring serious health risks. Heitor de Sá Gonçalves, president of the SBD, emphasized that
Studies have shown that e-cigarettes pose potential risks to public health, especially among young people. They not only impact skincare but also have the potential to damage multiple organs, including the lungs, leading to serious respiratory problems.
Aline Bressan, coordinator of the Dermatology and Internal Medicine Department, explains that in addition to promoting premature aging, the chemicals in e-cigarette liquid can cause redness and allergic reactions in the skin, delay healing, and worsen existing inflammatory skin conditions such as acne.
Toxins accumulation can also lead to issues such as melasma, thinning hair, weak and yellowing nails.
The Brazilian Society of Dermatology (SBD) and 79 medical institutions, including the Brazilian Medical Association (AMB) and the Brazilian Society of Pulmonology and Tuberculosis (SBPT), jointly signed a letter this week opposing Bill No. 5008 of 2023. The bill attempts to allow the regulated sale of e-cigarettes in Brazil.
This letter has been submitted to the Senate committee, highlighting the opposition of various medical institutions.
Gonzalves stated that,
We believe that legislation should protect public health, so we have joined forces with other groups to oppose the sale of products that lack safety evidence.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
